TobaccoReporter logo

Tag: Q3

  • Pyxus Reports Strong 3Q Results

    Pyxus Reports Strong 3Q Results

    Pyxus International reported third-quarter fiscal 2026 net income of $16.9 million, with adjusted EBITDA holding steady at $80 million, as increased shipping volumes and third-party processing offset lower leaf product revenues. Quarterly sales fell to $655.8 million from $778.3 million a year earlier, largely due to shipment timing and lower average pricing in South America. The company reaffirmed full-year guidance of $2.4 billion to $2.6 billion in net sales and $215 million to $235 million in adjusted EBITDA, while warning that strong global crop production could lead to oversupply heading into fiscal 2027.

    Tobacco inventory at the end of the third quarter was $959.8 million, compared to $755.2 million at the same time last year, reflecting procurement of the larger current crops. Uncommitted inventory as a percentage of total processed tobacco remains unchanged from the prior year. At December 31, 2025, uncommitted inventory was $28 million, or 3.6%, of the $768.6 million in total processed inventory, compared to $21.9 million, or 3.6%, of total processed inventory of $603.3 million at December 31, 2024.

  • Universal Posts Nine-Month, Q3 Results

    Universal Posts Nine-Month, Q3 Results

    Universal Corporation reported “solid results” for the nine months and third quarter ended December 31, 2025, supported by continued strength in its tobacco operations despite softer overall volumes and headwinds in its ingredients business. Nine-month revenue declined 2% to $2.2 billion, and operating income fell 3% to $183 million, reflecting lower tobacco sales volumes and higher fixed costs, although customer demand for most tobacco styles remained firm and third-party processing volumes increased. Third-quarter revenue dropped 8% to $861 million, with operating income down 21% to $82 million, driven by reduced tobacco shipments and inventory write-downs, while the ingredients segment faced tariff pressures, weaker consumer-packaged-goods demand, and higher depreciation costs. The company also strengthened liquidity through a refinancing and expansion of its revolving credit facility and highlighted sustainability progress, including a significant increase in renewable electricity use and continued farmer engagement across its global supply chain.

  • KT&G Reports Record Q3 Results, Raises Annual Outlook

    KT&G Reports Record Q3 Results, Raises Annual Outlook

    KT&G reported record-high third-quarter results, with revenue up 11.6% year-on-year to KRW 1.83 trillion ($1.3 billion) and operating profit rising 11.4% to KRW 465.3 billion ($321 million), the highest in five years. Strong global cigarette sales — up 24.9% — drove growth, while domestic and next-generation product sales remained solid, the company said.

    KT&G raised its annual revenue and profit guidance to double-digit growth and reaffirmed shareholder returns, including a KRW 6,000 ($4.14) minimum dividend per share and KRW 260 billion ($179 million) in stock buybacks.

    The company continues to move forward with plans to expand its nicotine pouch business through a joint acquisition of Another Snus Factory with Altria by year-end.

  • JT Reports Strong Q3 2025 Results, Raises Full-Year Forecasts

    JT Reports Strong Q3 2025 Results, Raises Full-Year Forecasts

    Japan Tobacco Inc. (JT) reported robust growth for the first nine months of 2025, with revenue up 13.2% to ¥2.63 trillion ($17.1 billion) and adjusted operating profit at constant FX up 27.2% to ¥849 billion ($5.5 billion), driven by solid pricing and higher tobacco volumes. The company also completed the transfer of its pharmaceutical business to Shionogi & Co., Ltd. and its subsidiary TORII PHARMACEUTICAL, marking a strategic shift to focus on its core tobacco operations.

    At the end of September 2025, total assets stood at ¥8.2 trillion ($53.2 billion), down ¥175.7 billion ($1.1 billion) year-to-date, mainly due to lower cash holdings, while equity increased to ¥4.17 trillion ($27.1 billion) on higher retained earnings. Operating cash flow remained strong at ¥287 billion ($1.9 billion), supported by steady contributions from the tobacco business, despite payments related to the Canadian litigation settlement.

    Reflecting strong performance, JT raised its full-year forecasts across all metrics, projecting a 13.1% rise in revenue and a 24.3% increase in adjusted operating profit at constant FX. CEO Masamichi Terabatake credited growth in the Ploom heated tobacco segment, with Ploom AURA and EVO premium sticks boosting Japan’s HTS market share to 15.5%. JT also announced a revised annual dividend of ¥234 ($1.52) per share, up ¥26 ($0.17), in line with record-high earnings and its shareholder return policy.

  • Turning Point to Host Q3 Call on November 5

    Turning Point to Host Q3 Call on November 5

    Turning Point Brands, Inc. announced it will host a conference call November 5 at 8:30 a.m. EST to review Q3 2025 results. Listeners in the U.S. can call 800 715-9871, while international listeners call +1 646 307-1963. The event ID is 6640134.

    Participants should call at least 10 minutes in advance and follow the audio prompts to register. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company’s website. The replay of the webcast will be available on the site two hours following the call.

  • PMI Reports Strong Q3 Based on Smoke-Free Surge

    PMI Reports Strong Q3 Based on Smoke-Free Surge

    Today (October 21), Philip Morris International reported strong third-quarter 2025 results, with adjusted diluted earnings per share rising 17.3% to $2.24, while reported EPS increased 13.2% to $2.23. The company said it achieved record smoke-free gross profit, supported by higher volumes and favorable pricing. Net revenues grew 5.9% on an organic basis, and adjusted operating income rose 7.5%, driven by strong performance in smoke-free products, despite a 3.2% decline in cigarette volumes.

    PMI’s smoke-free portfolio continued to expand rapidly, now accounting for 41% of total net revenues and 42% of gross profit. Volumes of smoke-free products rose 16.6%, led by the IQOS heated tobacco line and ZYN nicotine pouches. IQOS strengthened its market share across Europe and Asia, while ZYN’s U.S. offtake surged 39% following its return to full availability. The e-vapor brand VEEV also posted a 91% jump in shipments, solidifying PMI’s diversified presence across smoke-free categories.

    Reflecting this momentum, PMI raised its full-year adjusted EPS guidance and boosted its quarterly dividend by 8.9% to $1.47 per share. CEO Jacek Olczak said the company’s smoke-free business “continues to outgrow the industry by a clear margin,” adding that PMI is “on track to exceed” its 2024–2026 growth targets. Despite regulatory challenges in some markets, the company remains focused on transitioning adult smokers toward smoke-free alternatives and expanding its portfolio in 100 markets worldwide.